We are live on
!
Find out more
Insmed
INSM
INSM
106 hedge funds and large institutions have $557M invested in Insmed in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
195% more call options, than puts
Call options by funds: $5.71M | Put options by funds: $1.94M
72% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 25
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
5% more funds holding
Funds holding: 101 → 106 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less capital invested
Capital invested by funds: $716M → $557M (-$160M)
Holders
106
Holders Change
+5
Holders Change %
+4.95%
% of All Funds
2.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
43
Reduced
25
Closed
11
Calls
$5.71M
Puts
$1.94M
Net Calls
+$3.77M
Net Calls Change
+$2.88M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$8.04M |
| 2 |
Millennium Management
New York
|
+$5.22M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.93M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.26M |
| 5 |
Axa
Paris,
France
|
+$3.79M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$18.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.87M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$7.17M |
| 4 |
SAM
Senzar Asset Management
New York
|
-$3.69M |
| 5 |
Morgan Stanley
New York
|
-$3.29M |
